Increasing evidence shows that SH3GL2 is less expressed in a variety of carcinomas, including breast carcinoma 14, non‐small cell lung cancer 15, laryngeal carcinoma 16, urothelial carcinoma 17, and head and neck squamous cell carcinoma 18. The gene discussed is SH3GL2; the disease is breast carcinoma.